A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, ...

Singular Genomics (OMIC) announced key development milestones for its G4X Spatial Sequencer at the Advances in Genome Biology and Technology ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

At AGBT, Singular Genomics presented data demonstrating the G4X platform’s robust integrated multiomic performance. Immune-oncology-focused lung, kidney, colon, and breast panels showed high ...

Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...

Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...

The firm will test additional doses and use its proprietary drug response predictor to gather data that can inform a registrational study.